2020
DOI: 10.7150/ijbs.39629
|View full text |Cite
|
Sign up to set email alerts
|

Potential roles of extracellular vesicles in the pathophysiology, diagnosis, and treatment of autoimmune diseases

Abstract: Since extracellular vesicles (EVs) were discovered in 1983 in sheep reticulocytes samples, they have gradually attracted scientific attention and become a topic of great interest in the life sciences field. EVs are small membrane particles, released by virtually every cell that carries a variety of functional molecules. Their main function is to deliver messages to the surrounding area in both physiological and pathological conditions. Initially, they were thought to be either cell debris, signs of cell death,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
57
0
7

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 66 publications
(64 citation statements)
references
References 155 publications
(178 reference statements)
0
57
0
7
Order By: Relevance
“…At the same time, the EV content displaying dynamic disease-specific information has a high potential even in the development of new prognostic biomarkers. EVs have been already proposed as reliable diagnostic/prognostic biomarkers in many clinical settings, such as coronary artery disease [108], renal [109], liver [110], neurodegenerative [107], and autoimmune [111] diseases, as well as in systemic sclerosis [112], in urological [113], hepatobiliary [103], and hematological [114] malignances, and in breast [115], lung [116], and ovarian cancers [117], and in cancer care [118].…”
Section: Evs As Diagnostic and Prognostic Biomarkersmentioning
confidence: 99%
“…At the same time, the EV content displaying dynamic disease-specific information has a high potential even in the development of new prognostic biomarkers. EVs have been already proposed as reliable diagnostic/prognostic biomarkers in many clinical settings, such as coronary artery disease [108], renal [109], liver [110], neurodegenerative [107], and autoimmune [111] diseases, as well as in systemic sclerosis [112], in urological [113], hepatobiliary [103], and hematological [114] malignances, and in breast [115], lung [116], and ovarian cancers [117], and in cancer care [118].…”
Section: Evs As Diagnostic and Prognostic Biomarkersmentioning
confidence: 99%
“…Indeed, EVs may be involved in the presentation of intracellular self-antigens to the immune system. Antigen-presenting cells (APCs) can undergo intracellular transfer and effective antigen delivery to autoantigen-specific T cells through EVs, which represents a highly efficient mechanism of antigen presentation ( 23 25 ). Additionally, many types of tissue- or humoral-derived EVs have been discovered to possess immunomodulatory or tolerogenic activities.…”
Section: Extracellular Vesiclesmentioning
confidence: 99%
“…There is a great deal of evidence that implicates EVs in the regulation of homeostatic processes, which includes but is not limited to, roles in coagulation [ 64 ], stem cell renewal and expansion [ 65 ], and inflammation [ 66 ]. However, as with most mediators of cellular communications, the relationship between EVs and inflammation is also intimately linked with the pathogenic role of EVs during autoimmunity [ 67 ].…”
Section: Extracellular Vesicles: What Where and How?mentioning
confidence: 99%